A phase 3 randomized, double-blind, 12-week vehicle-controlled, parallel-group study assessing the efficacy and safety of CD5024 1% cream versus vehicle cream in subjects with papulopustular Rosacea
1% effort 6 subjects
Awarded By
- Galderma
Contributors
- Chen, Suephy C Prinicipal Investigator
Amount
- $75,000.00
Start/End
- March 1, 2012 - September 30, 2013